- citric acid monohydrate
GSL: General Sales Licence
This information is intended for use by health professionals
Citric Acid Monohydrate BP 125mg per 5ml.
For relief of the symptoms of coughs.
Adults, the elderly and children over 12 years: One 5ml spoonful, repeated up to four times per day.
Children under 12 years: Not recommended.
Keep out of the reach of children.
Not suitable for children under 12 years.
No adverse effects are known for the product, however, as with all medicines use should be avoided during pregnancy unless recommended by a doctor.
Tabulated list of adverse reaction(s)
Adverse reactions frequency are defined using the following convention:
Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
System organ class (MedDRA)
Immune System Disorders
Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Overdose with this preparation is unlikely to occur due to the low concentrations of the ingredients, however, in the event, treatment should be symptomatic.
Anise flavour (contains propylene glycol)
Sodium benzoate (E211)
24 months unopened. Discard 2 months after first opening.
Store below 25°C.
Amber glass bottle with plastic cap and liner or white 28mm cap with tamper evident band and EPE Saranex liner